107 related articles for article (PubMed ID: 11144527)
1. Evolutionary malignant resistance of cells to damaging factors as common biological defence mechanism in neoplastic development. Review of conception.
Monceviciute-Eringiene E
J Exp Clin Cancer Res; 2000 Sep; 19(3):335-48. PubMed ID: 11144527
[TBL] [Abstract][Full Text] [Related]
2. Neoplastic growth: the consequence of evolutionary malignant resistance to chronic damage for survival of cells (review of a new theory of the origin of cancer).
Monceviciūte-Eringiene E
Med Hypotheses; 2005; 65(3):595-604. PubMed ID: 15919162
[TBL] [Abstract][Full Text] [Related]
3. Cellular mechanisms of multidrug resistance of tumor cells.
Stavrovskaya AA
Biochemistry (Mosc); 2000 Jan; 65(1):95-106. PubMed ID: 10702644
[TBL] [Abstract][Full Text] [Related]
4. Cancer and malignant resistance of cells as phenomena of adaptation to damaging factors.
Monceviciute-Eringiene E
Med Hypotheses; 1996 May; 46(5):459-62. PubMed ID: 8735884
[TBL] [Abstract][Full Text] [Related]
5. Amine oxidase, spermine, and hyperthermia induce cytotoxicity in P-glycoprotein overexpressing multidrug resistant Chinese hamster ovary cells.
Lord-Fontaine S; Agostinelli E; Przybytkowski E; Averill-Bates DA
Biochem Cell Biol; 2001; 79(2):165-75. PubMed ID: 11310564
[TBL] [Abstract][Full Text] [Related]
6. A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence.
Sawicka M; Kalinowska M; Skierski J; Lewandowski W
J Pharm Pharmacol; 2004 Sep; 56(9):1067-81. PubMed ID: 15324475
[TBL] [Abstract][Full Text] [Related]
7. Ability to acquire drug resistance arises early during the tumorigenesis process.
Yagüe E; Arance A; Kubitza L; O'Hare M; Jat P; Ogilvie CM; Hart IR; Higgins CF; Raguz S
Cancer Res; 2007 Feb; 67(3):1130-7. PubMed ID: 17283147
[TBL] [Abstract][Full Text] [Related]
8. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance in cancer.
Baguley BC
Methods Mol Biol; 2010; 596():1-14. PubMed ID: 19949917
[TBL] [Abstract][Full Text] [Related]
10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
11. Intracellular P-glycoprotein in multidrug resistant tumor cells.
Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.
Alemán C; Annereau JP; Liang XJ; Cardarelli CO; Taylor B; Yin JJ; Aszalos A; Gottesman MM
Cancer Res; 2003 Jun; 63(12):3084-91. PubMed ID: 12810633
[TBL] [Abstract][Full Text] [Related]
13. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
14. [Resistance of hematologic neoplasm cells to cytostatics. Part II].
Kodydková K; Krejsek J
Cas Lek Cesk; 2000 Sep; 139(19):591-5. PubMed ID: 11192750
[TBL] [Abstract][Full Text] [Related]
15. Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein.
Konings WN; Poelarends GJ
IUBMB Life; 2002; 53(4-5):213-8. PubMed ID: 12120998
[TBL] [Abstract][Full Text] [Related]
16. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
17. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant hela cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide.
Souslova T; Averill-Bates DA
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1538-51. PubMed ID: 15590186
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of bacterial biocide and antibiotic resistance.
Poole K
Symp Ser Soc Appl Microbiol; 2002; (31):55S-64S. PubMed ID: 12481829
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
